Alfresa Holdings Corporation Unsponsored ADR logo

Alfresa Holdings Corporation Unsponsored ADR (ALFRY)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
13. 55
0
0%
$
2.46B Market Cap
- P/E Ratio
0.22% Div Yield
100 Volume
- Eps
$ 13.55
Previous Close
Add Transaction
Day Range
13.55 13.55
Year Range
12.42 16.81
Want to track ALFRY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ALFRY closed yesterday higher at $13.55, an increase of 0% from Friday's close, completing a monthly decrease of -1.8116% or -$0.25. Over the past 12 months, ALFRY stock lost -9.6667%.
ALFRY pays dividends to its shareholders, with the most recent payment made on Jun 03, 2026. The next announced payment will be in In 3 months on Dec 07, 2026 for a total of $0.00141.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

ALFRY Chart

People also search for

Tsingtao Brewery Co. Ltd. Sponsored ADR
$ 29
-4.8556%
Addtech AB Unsponsored ADR
$ 18.67
-0.0696%
China Resources Beer (Holdings) Company Limited ADR
$ 5.7
-2.0619%
China Mengniu Dairy Company Limited
$ 23.63
-1.4184%
Shiseido Company, Limited Sponsored ADR
$ 22.78
-0.1753%

Alfresa Holdings Corporation Unsponsored ADR (ALFRY) FAQ

What is the stock price today?

The current price is $13.55.

On which exchange is it traded?

Alfresa Holdings Corporation Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is ALFRY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.22%.

What is its market cap?

As of today, the market cap is 2.46B.

Has Alfresa Holdings Corporation Unsponsored ADR ever had a stock split?

No, there has never been a stock split.

Alfresa Holdings Corporation Unsponsored ADR Profile

Consumer Staples Distribution & Retail Industry
Consumer Staples Sector
Ryuji Arakawa CEO
OTC PINK Exchange
015509102 CUSIP
JP Country
12,525 Employees
29 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Alfresa Holdings Corporation is a prominent player in the pharmaceutical and medical device industry, with a broad spectrum of activities that span the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment. The company boasts an international presence, extending its vast array of services and products beyond the domestic market of Japan. Founded in 2003 and headquartered in Tokyo, Japan, Alfresa has strategically positioned itself in the healthcare sector by catering to a wide range of needs, from hospitals and clinics to drug stores and pharmacies. Through its extensive network of subsidiaries, Alfresa Holdings Corporation is dedicated to improving healthcare quality and accessibility by leveraging its deep industry knowledge and expansive product portfolio.

Products and Services

  • Ethical Pharmaceuticals Wholesaling
  • Alfresa plays a crucial role in the wholesale distribution of ethical pharmaceuticals, offering an extensive range of diagnostic reagents and medical devices/equipment. This segment primarily serves hospitals, clinics, and dispensing pharmacies, ensuring that healthcare providers have access to essential medical products for patient care.

  • Self-Medication Products Wholesaling
  • In this domain, Alfresa provides a wide array of over-the-counter drugs, health foods, supplements, and additional products. Targeting drug stores and pharmacies, the company supports the self-care practices of consumers by supplying quality self-medication products.

  • Manufacture and Marketing of Pharmaceuticals and Medical Devices
  • Alfresa not only markets but also engages in the manufacturing of active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices. This comprehensive involvement in the product lifecycle enables the company to ensure the highest quality standards and innovations in healthcare products.

  • Contract Manufacturing of Pharmaceuticals
  • The company extends its manufacturing prowess to other entities through contract manufacturing services. This allows Alfresa to collaborate with various partners in the healthcare industry, facilitating the production of pharmaceuticals under contracted terms.

  • Medical-Related Business
  • Beyond products, Alfresa Holdings Corporation operates a dispensing pharmacy business along with other medical-related ventures. This diversification ensures that the company can meet a broad spectrum of healthcare needs, contributing to the well-being of communities it serves.

Contact Information

Address: 1-1-3 Otemachi
Phone: 81 3 5219 5100